Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
98,567,360
-
Total 13F shares
-
26,061,019
-
Share change
-
-769,580
-
Total reported value
-
$110,514,000
-
Put/Call ratio
-
203%
-
Price per share
-
$4.24
-
Number of holders
-
60
-
Value change
-
-$387,734
-
Number of buys
-
36
-
Number of sells
-
42
Institutional Holders of ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY) as of Q2 2022
As of 30 Jun 2022 ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY) had 60 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 26,061,019 shares of stock of the company.
Largest 10 holders included ORBIMED ADVISORS LLC, FMR LLC, Nextech Invest AG, K2 PRINCIPAL FUND, L.P., Nantahala Capital Management, LLC, VANGUARD GROUP INC, Rubric Capital Management LP, BlackRock Inc., EcoR1 Capital, LLC, and RENAISSANCE TECHNOLOGIES LLC.
This table shows 60 institutional shareholders of the security as of 30 Jun 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.